Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The Pharma Letter
8m
Liquidia shares jump 11% on court ruling
Cardiopulmonary diseases specialist Liquidia saw an 11% rise in its stock after the US Supreme Court denied United ...
The Pharma Letter
19m
Efficacy and safety data show strong reduction in HIV infections with lenacapavir
US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...
The Pharma Letter
19m
Ebglyss FDA approval intensifies competition in atopic dermatitis market
With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Sex abuse case dismissed
Milton becomes Category 5
Human life expectancy study
Tickets to climb to $5
Richest female musician
Ranger dies during rescue
Harris on '60 Minutes'
Vanderbilt, Arkansas fined
Targeted by a cyberattack
King named grand marshal
Ordered to open app store
Settles latest civil lawsuit
NC voting rule changes
North Dakota wildfires
Hera mission launched
Athlete payments approval
Win Nobel Prize in physics
US overdose deaths drop
Launches asteroid probe
Grammy-winning singer dies
US antitrust case advances
TX emergency abortion case
Names new school board
Liquidation plan approved
Hamas backers sanctioned
IVF clinic's appeal rejected
SCOTUS denies appeal
Intel defensive briefings rise
Feedback